ARTL Past Earnings image   This ARTL past earnings page last updated 7/1/2022
ARTL Past Earnings
PeriodPast Earnings DateGAAP
Q2 20225/12/2022-0.050
Q1 20221/11/2022-0.080
Q4 202111/29/2021-0.070
Q3 20217/12/2021-0.100
Q2 20214/13/2021-0.110
Q1 20211/13/2021-0.140
Q4 202011/4/2020-0.190
Q3 20207/13/2020-0.270
Q2 20204/14/2020-0.400
Q1 20201/14/2020-0.400
Q4 201911/25/2019-0.420
Q3 20197/15/2019-0.400
ARTL Past Revenue
PeriodPast Earnings DateGAAP
Q2 20225/12/2022NA
Q1 20221/11/2022NA
Q4 202111/29/2021NA
Q3 20217/12/2021NA
Q2 20214/13/2021NA
Q1 20211/13/2021NA
Q4 202011/4/2020NA
Q3 20207/13/2020NA
Q2 20204/14/2020NA
Q1 20201/14/2020NA
Q4 201911/25/2019NA
Q3 20197/15/2019NA
Quotes delayed 20 minutes

Email EnvelopeFree ARTL Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Artelo Biosciences (ARTL) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

ARVN Historical Earnings
ARWR Historical Earnings
ASMB Historical Earnings
ASRT Historical Earnings
ATEC Historical Earnings
ATHA Historical Earnings
ATHX Historical Earnings
ATNF Historical Earnings
ATNX Historical Earnings
ATOS Historical Earnings

ARTL Past Earnings Q&A

What was the best and worst ARTL past earnings results?
For Artelo Biosciences, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest ARTL past earnings result in our data set was -0.050/share posted in Q2 2022, while the lowest was in Q4 2019 when ARTL posted -0.420/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q2 2022 when ARTL reported NA in revenue, while the quarter with the lowest revenue in our data set was Q2 2022 at NA of revenue.

  Suggested answer: There are 12 ARTL past earnings results in our data set.

On this page we presented the ARTL past earnings date information for Artelo Biosciences. Reviewing that ARTL Past Earnings for the company, we see that the highest past earnings result in our data set was in Q2 2022, when ARTL posted gaap of -0.050/share. Meanwhile the lowest ARTL past earnings result was in Q4 2019, when ARTL posted gaap of -0.420/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q2 2022 when ARTL reported NA in revenue, while the smallest revenue quarter was Q2 2022 when ARTL reported NA in revenue.

Any self directed investor doing their due diligence on ARTL or any other given stock can benefit from researching all of the Artelo Biosciences past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Artelo Biosciences past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for ARTL. Thanks for visiting, and the next time you need to research ARTL past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: UNT market cap history, Top Ten Hedge Funds Holding TDSB, Top Ten Hedge Funds Holding GLOW.

 

ARTL Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.